DKK 28.0
(-0.43%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 5.1 Billion DKK | 10.73% |
2022 | 4.45 Billion DKK | 26.35% |
2021 | 3.5 Billion DKK | -24.14% |
2020 | 4.94 Billion DKK | 24.4% |
2019 | 4.78 Billion DKK | -20.25% |
2018 | 5.28 Billion DKK | 11.06% |
2017 | 5.62 Billion DKK | 8.24% |
2016 | 3.57 Billion DKK | 706.83% |
2015 | 498 Million DKK | 21.76% |
2014 | 1.86 Billion DKK | -76.67% |
2013 | 1.75 Billion DKK | -31.2% |
2012 | 2.54 Billion DKK | -27.39% |
2011 | 4.28 Billion DKK | -22.54% |
2010 | 4.53 Billion DKK | 21.97% |
2009 | 3.5 Billion DKK | 112.62% |
2008 | 2.97 Billion DKK | -24.33% |
2007 | 2.3 Billion DKK | 57.02% |
2006 | 1.47 Billion DKK | -19.79% |
2005 | 1.84 Billion DKK | -41.86% |
2004 | 3.08 Billion DKK | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 1.74 Billion DKK | 2018.67% |
2024 Q2 | 1.49 Billion DKK | -42.91% |
2023 Q3 | 891 Million DKK | 6.07% |
2023 FY | - DKK | 10.73% |
2023 Q1 | 1.23 Billion DKK | 863.28% |
2023 Q2 | 840 Million DKK | -31.87% |
2023 Q4 | 83 Million DKK | -90.68% |
2022 Q1 | 875 Million DKK | 424.07% |
2022 FY | - DKK | 26.35% |
2022 Q4 | 128 Million DKK | -86.55% |
2022 Q3 | 952 Million DKK | 53.05% |
2022 Q2 | 622 Million DKK | -28.91% |
2021 Q3 | 526 Million DKK | -11.74% |
2021 Q2 | 596 Million DKK | -32.43% |
2021 Q1 | 882 Million DKK | 193.02% |
2021 Q4 | -270 Million DKK | -151.33% |
2021 FY | - DKK | -24.14% |
2020 Q2 | 747 Million DKK | 121.01% |
2020 FY | - DKK | 24.4% |
2020 Q4 | 301 Million DKK | -57.06% |
2020 Q3 | 701 Million DKK | -6.16% |
2020 Q1 | 338 Million DKK | 79.79% |
2019 Q2 | 1.1 Billion DKK | -7.92% |
2019 Q1 | 1.2 Billion DKK | 98.02% |
2019 FY | - DKK | -20.25% |
2019 Q3 | 1.01 Billion DKK | -8.42% |
2019 Q4 | 188 Million DKK | -81.42% |
2018 FY | - DKK | 11.06% |
2018 Q4 | 606 Million DKK | -58.12% |
2018 Q3 | 1.44 Billion DKK | 7.19% |
2018 Q2 | 1.35 Billion DKK | -13.46% |
2018 Q1 | 1.56 Billion DKK | 39.91% |
2017 Q3 | 1.41 Billion DKK | 34.76% |
2017 Q2 | 1.05 Billion DKK | 3.86% |
2017 Q1 | 1.01 Billion DKK | 9.53% |
2017 FY | - DKK | 8.24% |
2017 Q4 | 1.11 Billion DKK | -21.2% |
2016 Q3 | 589 Million DKK | 25.59% |
2016 FY | - DKK | 706.83% |
2016 Q2 | 469 Million DKK | -2.9% |
2016 Q4 | 923 Million DKK | 56.71% |
2016 Q1 | 483 Million DKK | 435.42% |
2015 FY | - DKK | 21.76% |
2015 Q4 | -144 Million DKK | 90.52% |
2015 Q3 | -1.51 Billion DKK | 68.57% |
2015 Q2 | -4.83 Billion DKK | -15003.13% |
2015 Q1 | -32 Million DKK | 93.94% |
2014 Q2 | 274 Million DKK | -51.85% |
2014 Q3 | 94 Million DKK | -65.69% |
2014 Q4 | -528 Million DKK | -661.7% |
2014 FY | - DKK | -76.67% |
2014 Q1 | 569 Million DKK | 156.31% |
2013 Q3 | 511 Million DKK | 200.99% |
2013 Q2 | -506 Million DKK | -133.16% |
2013 Q1 | 1.52 Billion DKK | 530.58% |
2013 FY | - DKK | -31.2% |
2013 Q4 | 222 Million DKK | -56.56% |
2012 Q2 | -118 Million DKK | -113.38% |
2012 FY | - DKK | -27.39% |
2012 Q3 | 661 Million DKK | 660.17% |
2012 Q4 | 242 Million DKK | -63.39% |
2012 Q1 | 882 Million DKK | 99.55% |
2011 Q4 | 442 Million DKK | -33.03% |
2011 FY | - DKK | -22.54% |
2011 Q3 | 660 Million DKK | -40.11% |
2011 Q2 | 1.1 Billion DKK | -15.56% |
2011 Q1 | 1.3 Billion DKK | 184.93% |
2010 Q1 | 1.88 Billion DKK | 377.92% |
2010 Q3 | 846 Million DKK | -9.62% |
2010 Q4 | 458 Million DKK | -45.86% |
2010 Q2 | 936 Million DKK | -50.29% |
2010 FY | - DKK | 21.97% |
2009 FY | - DKK | 112.62% |
2009 Q1 | 1.66 Billion DKK | 0.0% |
2009 Q2 | 719 Million DKK | -56.82% |
2009 Q3 | 784 Million DKK | 9.04% |
2009 Q4 | 394 Million DKK | -49.74% |
2008 FY | - DKK | -24.33% |
2007 FY | - DKK | 57.02% |
2006 FY | - DKK | -19.79% |
2005 FY | - DKK | -41.86% |
2004 FY | - DKK | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
H. Lundbeck A/S | 5.1 Billion DKK | 0.0% |
Stenocare A/S | -12.56 Million DKK | 40713.026% |